Dr. David Huntsman has been awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research by the Ovarian Cancer Research Alliance (OCRA), recognizing his findings that have profoundly impacted the treatment of certain ovarian cancer subtypes.
Dr. Huntsman is a distinguished scientist at the BC Cancer Research Institute, and professor of Pathology and Laboratory Medicine and Obstetrics and Gynaecology at the University of British Columbia. He is being recognized for research demonstrating that ovarian cancer subtypes should be treated as distinct diseases – an approach that has led to improved patient outcomes. Dr. Huntsman is also a co‑founder of OVCARE, a BC‑based multidisciplinary ovarian cancer research team that has evolved into the Gynecologic Cancer Initiative.
Reflecting on his career, Dr. Huntsman shared:
“I was drawn to ovarian cancer research by two brilliant and inspiring women (the late Nelly Auersperg, MD, PhD, and Dianne Miller, BSc, MD, FRCSC). My own research has contributed to change, but the growing impact and potential of our team astounds and excites me.”
The Rosalind Franklin Prize is a $10,000 annual award that honours senior researchers whose work has significantly advanced basic, translational or clinical research in ovarian cancer.
Congratulations to Dr. Huntsman!
This article has been adapted from its original version. Read the Ovarian Cancer Research Alliance announcement: Ovarian Cancer Research Alliance Honors Researchers with 2025 Rosalind Franklin and Schreiber Prizes